Issue 35, 2018

Synthesis and biological activity of a CXCR4-targeting bis(cyclam) lipid

Abstract

A bis(cyclam)-capped cholesterol lipid designed to bind C–X–C chemokine receptor type 4 (CXCR4) was synthesised in good overall yield from 4-methoxyphenol through a seven step synthetic route, which also provided a bis(cyclam) intermediate bearing an octaethyleneglycol-primary amine that can be easily derivatised. This bis(cyclam)-capped cholesterol lipid was water soluble and self-assembled into micellar and non-micellar aggregates in water at concentrations above 8 μM. The bioactivity of the bis(cyclam)-capped cholesterol lipid was assessed using primary chronic lymphocytic leukaemia (CLL) cells, first with a competition binding assay then with a chemotaxis assay along a C–X–C motif chemokine ligand 12 (CXCL12) concentration gradient. At 20 μM, the bis(cyclam)-capped cholesterol lipid was as effective as the commercial drug AMD3100 for preventing the migration of CLL cells, despite a lower affinity for CXCR4 than AMD3100.

Graphical abstract: Synthesis and biological activity of a CXCR4-targeting bis(cyclam) lipid

Supplementary files

Article information

Article type
Paper
Submitted
18 Jun 2018
Accepted
17 Aug 2018
First published
20 Aug 2018

Org. Biomol. Chem., 2018,16, 6479-6490

Synthesis and biological activity of a CXCR4-targeting bis(cyclam) lipid

A. D. Peters, C. McCallion, A. Booth, J. A. Adams, K. Rees-Unwin, A. Pluen, J. Burthem and S. J. Webb, Org. Biomol. Chem., 2018, 16, 6479 DOI: 10.1039/C8OB01439F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements